Additional file 7: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Gnanapragasam, V.; Bratt, O.; Muir, K.; Lee, L.; Huang, H.; Stattin, P.; Lophatananon, A.

doi:10.6084/m9.figshare.5938018.v1

12916_2018_1019_MOESM7_ESM.docx (15.25 kB)

Additional file 7: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

journal contribution

posted on 2018-02-28, 05:00 authored by V. Gnanapragasam, O. Bratt, K. Muir, L. Lee, H. Huang, P. Stattin, A. Lophatananon

Table S7. Distribution of cases and deaths from prostate cancer and hazard ratios for each Cambridge Prognostic Group (CPG) in the PCBaSe radical radiotherapy cohort (n = 11,872). (DOCX 15 kb)

History

Usage metrics

Keywords

Prostate cancer Prognostic prediction Cancer-specific mortality Cambridge Prognostic Groups Non-metastatic disease Stratification All-cause mortality Competing risks Improved treatment section Treatment selection

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 7: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

History

Usage metrics

Categories

Keywords

Licence

Exports